C

CAI

CAI

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
33%Bearish
Buy/Sell Ratio8% buys
BearishBullish
CAI Live QuoteReal-time
$18.54
$13.81(-42.69%)1M
Day Range$18.52 – $20.82
Open$19.86
Previous Close$19.50
Volume3.63M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$5.59B
P/E Ratio (TTM)11.8
Forward P/E27.3
EPS (TTM)$1.66
Price to Book8.9
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $18.54 (19%)
Low: $14.19High: $36.50
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$34.23-77.2% upside

Insider Buys

6

$2.39M

Insider Sales

4

$28.86M

Total Volume

$31.25M

18 transactions

Net Activity

$26.47M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
55CONFIDENCE

Sentiment Rating

Neutral / Balanced

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 92% of total transaction value.
  • •Cluster buying: 5 unique insiders purchased shares, showing strong alignment.
  • •High accumulation: total purchase value exceeds $1M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale Insiders

0 buys8 sells

$102.42B total

S
2

Spetzler David Baxley

Pres

1 buys1 sells

$14.84M total

B
3

Brille Brian J

See Remarks

1 buys1 sells

$12.76M total

P
4

Power Luke Thomas

See Remarks

0 buys1 sells

$1.65M total

H
5

Halbert Jon

Dir

1 buys0 sells

$990K total

Trading History
CAI insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 22, 2026

1 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell184.0K$-7500.00$0

Sep 22, 2026

1 months ago

Denton John Russel

See Remarks

Insider
Sell7.5K$31.82$239K

Sep 17, 2026

2 months ago

Brille Brian J

See Remarks

Insider
Sell400.0K$30.33$12.13M

Sep 17, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell730.3K$-400000.00$0

Sep 3, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell1.18M$-597212.00$0

Sep 3, 2026

2 months ago

Spetzler David Baxley

Pres

President
Sell597.2K$24.84$14.83M

May 15, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.46M$68000.00$99.36B

May 15, 2026

6 months ago

Halbert Jon

Dir

Director
Buy68.0K$14.56$990K

May 11, 2026

6 months ago

Vacirca Jeff L

Dir

Director
Buy31.1K$16.15$501K

May 11, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell49.7K$31050.00$1.54B

Dec 11, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell99.6K$-62250.00$0

Dec 11, 2025

11 months ago

Power Luke Thomas

See Remarks

Insider
Sell62.3K$26.58$1.65M

Nov 7, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell132.8K$4184.00$555.53M

Nov 7, 2025

12 months ago

Denton John Russel

See Remarks

Insider
Buy4.2K$24.09$101K

Nov 7, 2025

12 months ago

Spetzler David Baxley

Pres

President
Buy400$23.85$10K

Jun 20, 2025

17 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell128.6K$7500.00$964.43M

Jun 20, 2025

17 months ago

Brille Brian J

See Remarks

Insider
Buy30.0K$21.00$630K

Jun 20, 2025

17 months ago

Denton John Russel

See Remarks

Insider
Buy7.5K$21.00$158K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
CAI Buy Conviction8%
Industry Rank#0 of 570
Volume Contribution0.2%
Total Industry Activity$16.44B

CAI has an insider buy conviction of 8%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for CAI

Over the last 90 days, corporate insiders at CAI (CAI) engaged in a total of 18 transactions reported via SEC Form 4 filings. Among these, 6 were open-market purchases and 4 were sales. The total volume of insider trading reached $31.25M.

The net insider activity for CAI shows a net selling bias of $26.47M. This activity represents a 8% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.46M shares valued at $99.36B on May 15, 2026.

Live Market News & Developments
Aggregated real-time headlines for CAI (CAI)
6 updates

Caris Life Sciences, Inc. (CAI) stock price, news, quote and history

Yahoo Finance UKYesterday

Caris Life Sciences (NDQ:CAI): Its Molecular Profiling Business Is Already Working, Now Investors Must Decide If Its Precision Oncology Platform Can

Stocks Down Under9h ago

Caris Life Sciences (NasdaqGS:CAI) Stock Forecast & Analyst Predictions

Simply Wall St9d ago

Caris Life Sciences, Inc. (NASDAQ:CAI) Stock Has Average Price Target of $31.18

MarketBeat7d ago

$CAI stock is down 10% today. Here's what we see in our data. | CAI Stock News

Quiver Quantitative44d ago

CAI - Caris Life Sciences Inc Stock Price and Quote

Finviz177d ago

FAQs About CAI Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for CAI.

Based on SEC Form 4 disclosures, the Insider Confidence Score for CAI is currently 55/100, which reflects a neutral / balanced bias. This calculation accounts for a total of 6 purchases and 4 sales by company executives over the last 90 days.

The CEO Conviction Index for CAI is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.